Biotechnology | Disease | FDA
FDA approved an expanded indication for ENBREL (etanercept) to inhibit progression of structural damage of active arthritis
On Aug. 25, 2003, The U.S. Food and Drug Administration (FDA) announced it had approved an expanded indication…
